FDA Inspection 1326418 — Doris G. Leung, MD, PhD

Doris G. Leung, MD, PhD — FEI 3044854587

The FDA completed an inspection of Doris G. Leung, MD, PhD on Jul 10, 2026 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 10, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baltimore, MD (United States)